{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/shingles/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"ea603e45-ec07-5201-a182-ebef4c48ef6b","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 8907570f-17aa-4ef5-bc81-8acad5e63080 --><h2>Update</h2><!-- end field 8907570f-17aa-4ef5-bc81-8acad5e63080 -->","summary":null,"htmlStringContent":"<!-- begin item 109513be-ddc9-49b7-ac11-90c501c070c1 --><!-- end item 109513be-ddc9-49b7-ac11-90c501c070c1 -->","topic":{"id":"012e484d-8c14-5168-bb5d-e5acb7d4571a","topicId":"2969a8ac-cb7f-4569-be79-822e6009081a","topicName":"Shingles","slug":"shingles","lastRevised":"Last revised in October 2020","chapters":[{"id":"eeb1b918-6c05-5340-b348-ce2809516623","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ad8b1b2-36bb-5262-ab5a-05763d6e4c7d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b1aed669-8481-5315-ab58-4bb18606e360","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8fef2c66-91dc-57c6-8cd3-4e4eff8d7727","slug":"changes","fullItemName":"Changes"},{"id":"ea603e45-ec07-5201-a182-ebef4c48ef6b","slug":"update","fullItemName":"Update"}]},{"id":"81feec28-1a5d-5a24-9c52-bee13821b03b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bb672f83-c2bd-5dd7-9934-78f09729db48","slug":"goals","fullItemName":"Goals"},{"id":"2036bd3f-37bc-5cea-887d-55c3fc68c7cf","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"cc04b460-a0d8-5e8d-b8d0-c044947b4bd6","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ee3573cb-38d5-5d4c-9c9d-cd274242d964","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"52999d3b-9cce-59c5-b588-1f7ad7de33e2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"40a91fd6-3c01-5713-85ad-0a5c4379eab9","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"04a0af22-814d-5b14-b28c-7916f1772a4d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"097dfec6-754a-54a8-9d96-44e1c5704248","slug":"definition","fullItemName":"Definition"},{"id":"f20034b1-ae3e-505b-ac16-3e11f2a6653e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e92f0243-b1ac-50d9-a31a-a07a4c61c5a7","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b6f8c581-b332-5d26-ba45-ccfb7189a387","slug":"complications","fullItemName":"Complications"},{"id":"012c8f32-e9cf-5897-a695-4c21cd28ae5d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"81f3feff-d640-5ee2-83fa-af1a4e8b586a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"56b89dcf-d466-50f3-a8a0-3a9477ef3362","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"01bc96b7-ea05-59b9-963a-16b2722b9367","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"acd9aec2-87d6-5084-bd3a-5c0b1d164ab4","fullItemName":"Management","slug":"management","subChapters":[{"id":"9872f447-6f59-502d-b6cb-a0fae6d2c085","slug":"management","fullItemName":"Scenario: Management"},{"id":"9ecdcc36-4fec-5b60-aa42-2032f2c406a4","slug":"prevention","fullItemName":"Scenario: Prevention"}]},{"id":"929d18e1-e1f0-5d08-8c55-d289b349a9fd","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4445c1da-4f7a-5f12-a909-0112bbd72453","slug":"antiviral-drugs","fullItemName":"Antiviral drugs"},{"id":"1223613b-f5a6-5da6-a311-275f5d6181b2","slug":"zostavax","fullItemName":"Zostavax"}]},{"id":"67979756-a00f-5f10-a93e-81509b35e1a8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"625749c2-4e09-57ba-bdee-cd206d8b02d5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"377ce207-6229-5548-aef7-a637f176a94e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"19ac0831-d4e2-52c3-b127-e78b1f26fb6f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d46d7aff-a113-50d5-afa1-3310aad844d7","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d23205e9-41c9-5c70-a9f9-5ce3cfae633a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"cf98894b-c083-59fd-8150-f390845960f1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a52b727c-ba28-5973-9e3c-e4882a883593","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b1aed669-8481-5315-ab58-4bb18606e360","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"3392dc1c-8d63-58ec-91f1-090268aa51f4","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field ca0598d2-79bc-492c-adcd-15bf051a9140 --><h3>New evidence</h3><!-- end field ca0598d2-79bc-492c-adcd-15bf051a9140 -->","summary":null,"htmlStringContent":"<!-- begin item 73b180c1-0482-4678-9994-784e8acea7c6 --><!-- begin field b14b4aa6-4a29-4808-8a53-2086567187c6 --><h3>Evidence-based guidelines</h3><!-- end field b14b4aa6-4a29-4808-8a53-2086567187c6 --><!-- begin field 0eebc4ca-3b77-4c25-a3a6-f2b7e50cb69f --><p>No new evidence-based guidelines since 1 September 2019.</p><!-- end field 0eebc4ca-3b77-4c25-a3a6-f2b7e50cb69f --><!-- begin field ef6becf5-8fb1-47b5-aa4b-065ff41fb5e1 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field ef6becf5-8fb1-47b5-aa4b-065ff41fb5e1 --><!-- begin field f6fc145c-2291-4e03-a40a-8b8daace8c5c --><p>No new HTAs since 1 September 2019.</p><!-- end field f6fc145c-2291-4e03-a40a-8b8daace8c5c --><!-- begin field 4bcfc6f0-2cca-484f-9d9f-301f8e64d22d --><h3>Economic appraisals</h3><!-- end field 4bcfc6f0-2cca-484f-9d9f-301f8e64d22d --><!-- begin field 89be197a-ce9f-4593-b959-4d3d5143cda4 --><p>No new economic appraisals relevant to England since 1 September 2019.</p><!-- end field 89be197a-ce9f-4593-b959-4d3d5143cda4 --><!-- begin field c8dfef4b-826a-403e-aa78-1021d79db5b9 --><h3>Systematic reviews and meta-analyses</h3><!-- end field c8dfef4b-826a-403e-aa78-1021d79db5b9 --><!-- begin field 0b06da55-d09f-4552-abe9-d75bde6545f3 --><ul><li>Gagliardi, A., Andriolo, B., Torloni, M., et al. (2019)Â <em>Vaccines for preventing herpes zoster in older adults. </em>Cochrane Library. <a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"da259490-2030-4bc7-abe0-ab0a00ba97c5\">www.cochranelibrary.com</a> [<a href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008858.pub4/full?highlightAbstract=withdrawn\" data-hyperlink-id=\"9296ee91-b0f0-4093-b58e-ab0a00ba981c\">Free Full-text</a>]</li></ul><!-- end field 0b06da55-d09f-4552-abe9-d75bde6545f3 --><!-- begin field 23b8327c-b345-43fd-9bdd-70d8203f903b --><h3>Primary evidence</h3><!-- end field 23b8327c-b345-43fd-9bdd-70d8203f903b --><!-- begin field b67ea911-314b-46f5-8229-fc82918cbbf2 --><p>No new randomized controlled trials published in the major journals since 1 September 2019.</p><!-- end field b67ea911-314b-46f5-8229-fc82918cbbf2 --><!-- end item 73b180c1-0482-4678-9994-784e8acea7c6 -->","subChapters":[]},{"id":"d0ed3f59-ba07-50f1-8fee-40eb13b8e926","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 1dc613b8-648d-44b0-a0bd-d1440c70e9f2 --><h3>New policies</h3><!-- end field 1dc613b8-648d-44b0-a0bd-d1440c70e9f2 -->","summary":null,"htmlStringContent":"<!-- begin item 0a3a420a-ba31-4b46-9705-8d7e65d23ed4 --><!-- begin field 9ed595b7-8a65-4cce-a078-eb42a0470500 --><p>No new national policies or guidelines since 1 September 2019.</p><!-- end field 9ed595b7-8a65-4cce-a078-eb42a0470500 --><!-- end item 0a3a420a-ba31-4b46-9705-8d7e65d23ed4 -->","subChapters":[]},{"id":"8b1c42ff-eccb-513f-a2b2-6da636352bbc","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 39e64992-efb5-49ee-b2bc-7cd965261799 --><h3>New safety alerts</h3><!-- end field 39e64992-efb5-49ee-b2bc-7cd965261799 -->","summary":null,"htmlStringContent":"<!-- begin item 68cf208f-ea79-4296-987d-179fdfecfec4 --><!-- begin field efb0aeef-a058-4d4d-8b61-0a03a87489a4 --><p>No new safety alerts since 1 September 2019.</p><!-- end field efb0aeef-a058-4d4d-8b61-0a03a87489a4 --><!-- end item 68cf208f-ea79-4296-987d-179fdfecfec4 -->","subChapters":[]},{"id":"380634ec-607c-53d7-9a21-cf6d85b4e57a","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 7d8ef322-f09a-44bb-9ad2-6fcc05216106 --><h3>Changes in product availability</h3><!-- end field 7d8ef322-f09a-44bb-9ad2-6fcc05216106 -->","summary":null,"htmlStringContent":"<!-- begin item 9c86a5cd-bb3e-4597-a391-e421e9bcc6dc --><!-- begin field 04837c7f-aa84-40fb-a8ca-23630dd8db2a --><ul><li>Shingrix herpes zoster vaccine (recombinant, adjuvanted) can be licensed for prevention of herpes zoster and post-herpetic neuralgia, in adults 50 years or older, and in adults 18 years or older at increased risk of herpes zoster. See more <a href=\"https://www.ema.europa.eu/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-shingrix-ii-22_en.pdf\" data-hyperlink-id=\"0fd9f73e-4378-4a8b-bef7-ac090094509d\">here</a>.</li></ul><!-- end field 04837c7f-aa84-40fb-a8ca-23630dd8db2a --><!-- end item 9c86a5cd-bb3e-4597-a391-e421e9bcc6dc -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}